Daniel Petrylak outlines the RANGE trial results for use of ramucirumab in patients with advanced urothelial carcinoma.
25-09-2017 | Urothelial cancer | ESMO 2017 | Video
25-09-2017 | Urothelial cancer | ESMO 2017 | Video
Daniel Petrylak outlines the RANGE trial results for use of ramucirumab in patients with advanced urothelial carcinoma.